ENDOSOL LTD

Registered Number
13839819
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

ENDOSOL LTD

Company Information
for the year from 1 February 2025 to 31 January 2026


Directors	GORIA, Rahul Vinod, Dr
	MASIH, Joseph, Dr


Registered Address	51 High Street
	Great Missenden
	HP16 0AL


Registered Number	13839819 (England and Wales)

ENDOSOL LTD

Balance Sheet as at
31 January 2026

	Notes	2026		2025
		£	£	£	£
Current assets
Cash at bank and on hand		2		21
		2		21
Creditors amounts falling due within one year	3	(18,518)		(17,795)
Net current assets (liabilities)			(18,516)		(17,774)
Total assets less current liabilities			(18,516)		(17,774)
Accruals and deferred income			(480)		(480)
Net assets			(18,996)		(18,254)
Capital and reserves
Profit and loss account			(18,996)		(18,254)
Shareholders' funds			(18,996)		(18,254)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 12 October 2026, and are signed on its behalf by:

MASIH, Joseph, Dr
Director
Registered Company No. 13839819

ENDOSOL LTD

Notes to the Financial Statements
for the year ended 31 January 2026

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Revenue from sale of goods
	Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

Revenue from sale of goods

Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

2.	Average number of employees


		2026		2025
	Average number of employees during the year	0		0

3.	Creditors: amounts due within one year

	2026	2025
	£	£
Other creditors	18,518	17,795
Total	18,518	17,795


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.